Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 24.32%436.18B | 25.28%1.6T | 29.74%428.42B | 31.26%446.93B | 14.67%375.51B | 25.16%350.84B | 22.36%1.28T | 41.16%330.2B | 21.17%340.48B | 23.16%327.48B |
Cost of revenue | 1.47%95.05B | 14.25%415.32B | -1.34%104.56B | 24.88%122.35B | 11.76%94.74B | 25.24%93.68B | 2.87%363.53B | 19.31%105.98B | 6.57%97.97B | -3.02%84.77B |
Gross profit | 32.65%341.13B | 29.66%1.19T | 44.44%323.86B | 33.84%324.58B | 15.68%280.77B | 25.13%257.16B | 32.32%914.95B | 54.53%224.22B | 28.26%242.5B | 35.98%242.71B |
Operating expense | 16.43%248.15B | 22.71%974.78B | 32.96%306.82B | 6.70%225.09B | 26.57%229.74B | 24.54%213.13B | 28.44%794.37B | 17.83%230.77B | 40.60%210.95B | 30.10%181.51B |
Selling and administrative expenses | 28.21%175.12B | 35.18%637B | 41.77%199.06B | 32.55%160.33B | 24.27%141.03B | 41.72%136.58B | 30.01%471.22B | 31.82%140.41B | 34.21%120.96B | 34.21%113.49B |
-General and administrative expense | 28.21%175.12B | 35.18%637B | 41.77%199.06B | 32.55%160.33B | 24.27%141.03B | 41.72%136.58B | 30.01%471.22B | 31.82%140.41B | 34.21%120.96B | 34.21%113.49B |
Research and development costs | 30.54%100.71B | 6.91%365.17B | 6.87%108.11B | 1.35%90.97B | 17.45%88.94B | 2.96%77.15B | 31.21%341.57B | 10.94%101.16B | 49.41%89.76B | 37.59%75.72B |
Other operating expenses | ---- | -87.06%88M | -67.27%72M | -97.61%11M | --5M | ---- | 22,566.67%680M | --220M | 15,233.33%460M | ---- |
Total other operating income | 4,468.15%27.68B | 43.85%27.48B | -96.24%414M | 11,709.91%26.22B | -96.91%238M | 260.71%606M | 342.05%19.1B | 495.03%11.01B | 31.36%222M | 10,161.33%7.7B |
Operating profit | 111.16%92.98B | 75.47%211.59B | 360.15%17.04B | 215.32%99.49B | -16.61%51.03B | 28.07%44.03B | 65.12%120.58B | 87.09%-6.55B | -19.17%31.55B | 57.03%61.2B |
Net non-operating interest income (expenses) | 112.00%17.16B | 304.59%25.46B | 243.92%20.27B | -138.08%-1.78B | -268.48%-1.12B | 263.68%8.09B | 1,643.21%6.29B | 449.11%5.89B | 433.26%4.68B | 630.40%663M |
Non-operating interest income | 116.90%19.13B | 113.14%31.49B | 79.08%9.96B | 40.37%9.73B | 42.95%4.82B | 464.72%8.82B | 141.63%14.77B | 351.22%5.56B | 209.84%6.93B | 471.02%3.37B |
Non-operating interest expense | 171.53%1.97B | -28.94%6.03B | -2,987.43%-10.31B | 412.38%11.51B | 119.25%5.93B | -88.83%727M | 47.40%8.48B | -111.44%-334M | 65.39%2.25B | 278.46%2.71B |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | 900.00%60M | 1,068.42%184M | 36.07%83M | 193.62%44M | 545.45%49M | 128.57%6M | -114.73%-19M | -4.69%61M | -313.64%-47M | -124.44%-11M |
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | 111.38%110.2B | 87.01%237.23B | 6,373.15%37.39B | 170.14%97.75B | -19.22%49.96B | 77.23%52.13B | 72.55%126.85B | 98.86%-596M | -9.38%36.19B | 59.03%61.85B |
Income tax | 608.61%24.82B | 105.01%36.22B | 102.05%473M | 293.29%30.65B | -55.48%9.97B | -146.19%-4.88B | 170.00%17.67B | 7.76%-23.08B | -3.52%7.79B | 92.26%22.39B |
Net income | 49.76%85.38B | 84.10%201.02B | 64.15%36.91B | 136.33%67.1B | 1.36%39.99B | 202.44%57.01B | 63.04%109.19B | 182.24%22.49B | -10.87%28.39B | 44.82%39.46B |
Net income continuous operations | 49.76%85.38B | 84.10%201.02B | 64.15%36.92B | 136.33%67.1B | 1.36%39.99B | 202.42%57.01B | 63.03%109.19B | 182.24%22.49B | -10.87%28.39B | 44.82%39.46B |
Noncontrolling interests | 285M | -252M | 537M | 0 | 0 | 0 | ||||
Net income attributable to the company | 49.76%85.38B | 83.84%200.73B | 65.27%37.17B | 134.43%66.56B | 1.36%39.99B | 202.44%57.01B | 63.04%109.19B | 182.24%22.49B | -10.87%28.39B | 44.82%39.46B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 49.76%85.38B | 83.84%200.73B | 65.27%37.17B | 134.43%66.56B | 1.36%39.99B | 202.44%57.01B | 63.04%109.19B | 182.24%22.49B | -10.87%28.39B | 44.82%39.46B |
Gross dividend payment | ||||||||||
Basic earnings per share | 49.97%44.6 | 83.83%104.69 | 65.36%19.38 | 134.37%34.71 | 1.36%20.86 | 202.24%29.74 | 62.99%56.95 | 182.13%11.72 | -10.89%14.81 | 44.73%20.58 |
Diluted earnings per share | 49.97%44.57 | 83.83%104.62 | 65.27%19.37 | 134.39%34.69 | 1.31%20.84 | 202.34%29.72 | 63.02%56.91 | 182.13%11.72 | -10.84%14.8 | 44.86%20.57 |
Dividend per share | 0 | 66.67%50 | 100.00%30 | 0 | 33.33%20 | 0 | 11.11%30 | 11.11%15 | 0 | 11.11%15 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |